Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, Connecticut
- Most recent report
- 8-K, filed Aug 10, 2026
- Filings on record
- 275 filings
- On EDGAR
- CIK 1935979
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 16
News 8 of 51
Prospectuses and Registrations 8 of 20
- 424B5 Prospectus supplement for an offering May 4, 2026
- S-3ASR Automatic shelf registration May 4, 2026
- S-8 Registration statement for an employee plan Mar 2, 2026
- 424B5 Prospectus supplement for an offering Nov 13, 2025
- 424B5 Prospectus supplement for an offering Nov 12, 2025
- 424B5 Prospectus supplement for an offering Oct 1, 2024
- 424B5 Prospectus supplement for an offering Sep 30, 2024
- 424B5 Prospectus supplement for an offering Aug 16, 2024
Proxies 8
- DEFA14A Extra proxy material Mar 13, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 13, 2026
- DEFA14A Extra proxy material Mar 18, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 18, 2025
- DEFA14A Extra proxy material Mar 18, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 18, 2024
- DEFA14A Extra proxy material Mar 23, 2023
- DEF 14A Proxy statement for a shareholder vote Mar 23, 2023
Ownership 8 of 154
- 3 Insider reported their initial holding Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 3 Insider reported their initial holding Jul 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 8, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- 4 Insider reported a trade Apr 30, 2026
- 4 Insider reported a trade Apr 30, 2026
- 4 Insider reported a trade Apr 30, 2026
Other 8 of 26
Everything here comes from Biohaven Ltd.'s own filings on SEC EDGAR. The filing list is rechecked every hour.